ReVision Optics Begins U.S. Clinical Trial Of The PresbyLens(R) For The Restoration Of Near Vision

Friday, April 9, 2010

Comments

Medical News Today

ReVision Optics, a leading company in the research, development and manufacture of custom optical products to correct and maintain vision, announced today that it has begun its US clinical trial of the PresbyLens® corneal inlay.

Full Story

The lesion seen below has been present for many years. The patient does not complain of pain, itching or growth. This is most consistent with:
1. apocrine hydrocystoma
2. basal cell carcinoma
3. chronic dacryocystitis
4. sebaceous cell carcinoma
Check The Answer

SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product
PanoCam™ LT Wide-field Digital Imaging System
The PanoCam LT represents the first ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

ReVision Optics Begins U.S. Clinical Trial Of The PresbyLens(R) For The Restoration Of Near Vision

Comments

Related Categories

Refractive Products and Equipment »

Corneal and Refractive Diagnostics »

Quick Quiz

The lesion seen below has been present for many years. The patient does not complain of pain, itching or growth. This is most consistent with:

AdGlare RMR Ad

Featured Products

SPECTRALIS Diagnostic Imaging Platform

PanoCam™ LT Wide-field Digital Imaging System

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us